Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically stable recombinant modified vaccinia Ankara (rMVA) vaccines and methods of preparation thereof

Genetically stable recombinant modified vaccinia Ankara (rMVA) vaccines and methods of preparation thereof

US Patent 11541114 · Granted Jan 3, 2023

Estimated economic value: $3,473,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of triplex CMV vaccine in CAR T cell therapy2025
Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and meth2025
Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and meth2025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2024
Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved sta2024
Expression system for expressing herpesvirus glycoprotein complexes2023
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2023
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2023
P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof2023
Expression system for expressing herpesvirus glycoprotein complexes2022
MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infec2022